Educational guide
DSIP 5mg Dosage Protocol | PeptideDosages.com
DSIP (5 mg Vial) Dosage Protocol DSIP Dosage Chart DSIP (Delta Sleep-Inducing Peptide) is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols, usually before bedtime. A 5 mg vial reconstituted with bacteriostatic water yields abo
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
DSIP (5 mg Vial) Dosage Protocol
DSIP Dosage Chart
DSIP (Delta Sleep-Inducing Peptide) is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols, usually before bedtime. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. This information is for research and educational use only.
Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
Typical daily range: 100–300 mcg once daily (gradual titration); advanced up to 500 mcg.
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation[1][2]. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read DSIP Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
Week 1
100 mcg
6 units (0.06 mL)
Week 2
150 mcg
9 units (0.09 mL)
Week 3
200 mcg
12 units (0.12 mL)
Weeks 4–8
250–300 mcg
15–18 units (0.15–0.18 mL)
Frequency: Inject once daily subcutaneously, typically in the evening before bedtime[5][6]. For ≤10-unit (≤0.10 mL) administrations (Weeks 1–2), consider 30- or 50-unit insulin syringes for improved readability.
Advanced / Extended Approach
Week 5
350–400 mcg
21–24 units (0.21–0.24 mL)
Weeks 6–8+
400–500 mcg
24–30 units (0.24–0.30 mL)
Note: Advanced dosing (beyond 300 mcg) is based on anecdotal experience; formal human studies have primarily used doses up to ~300 mcg daily[7]. Use the minimum effective dose and increase only if needed.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–12 week daily protocol with gradual titration.
Peptide Vials (DSIP, 5 mg each):
8 weeks at ~200 mcg/day avg ≈ 2–3 vials
12 weeks at ~200 mcg/day avg ≈ 3–4 vials
12 weeks at ~300 mcg/day avg ≈ 5–6 vials
Insulin Syringes (U-100):
Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
3 vials: 9 mL → 1 × 10 mL bottle
5 vials: 15 mL → 2 × 10 mL bottles
6 vials: 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes